Verrica Pharma bankrolls PhIII with a $75M IPO raise for lead skin drug – Endpoints News
The infusion of cash will be enough to fund lead product VP-102 through clinical development in the molluscum contagiosum indication (a viral skin … Read source
Click to rate this post!